Detalhe da pesquisa
1.
ELP2 negatively regulates osteoblastic differentiation impaired by tumor necrosis factor α in MC3T3-E1 cells through STAT3 activation.
J Cell Physiol
; 234(10): 18075-18085, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30847950
2.
Prophylactic Effects of NFκB Essential Modulator-Binding Domain Peptides on Bone Infection: An Experimental Study in a Rabbit Model.
J Inflamm Res
; 15: 2745-2759, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35509324
3.
Novel Elongator Protein 2 Inhibitors Mitigating Tumor Necrosis Factor-α Induced Osteogenic Differentiation Inhibition.
Biomed Res Int
; 2021: 3664564, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34853789
4.
Efficacy of NEMO-binding domain peptide used to treat experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus: an in-vivo study.
Antimicrob Resist Infect Control
; 8: 182, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31832182
5.
Discovery of novel elongator protein 2 inhibitors by compound library screening using surface plasmon resonance.
RSC Adv
; 9(3): 1696-1704, 2019 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35518050